Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Laparoscopic Pelvic and Para-aortic Lymphadenectomy and Uterine Blood Vessel Blocking for Precision Diagnosis and Treatment in Advanced Cervical Cancer

NCT02950350 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.

NCT NCT02950350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02950350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Laparoscopic Pelvic and Para-aortic Lymphadenectomy and Uterine Blood Vessel Blocking for Precision Diagnosis and Treatment in Advanced Cervical Cancer
Lead sponsor
Shanghai First Maternity and Infant Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2016
Completion date
December 31, 2023
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer stage iiia, cervical cancer stage iiib, cervical cancer, stage iib, cervical cancer, stage iva